A first in man study of CAR-T CD44v6.
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2018
At a glance
- Drugs CAR-CD44v6 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions
- 19 Mar 2018 New trial record
- 09 Mar 2018 According to a MolMed media release, company plans to initiate the first in man study in 2018.